Magnoliamedical
A Quality Manager in R&D and Operations QA/RA role at a high-growth medical device company focused on improving sample collection and integrity for in-vitro diagnostic testing. The role involves leading quality systems, regulatory compliance, and people leadership.
Headquarters
Seattle, Washington, United States
Company Size
51-200 employees
Founded
2006
Magnolia Medical Technologies is a medical device company and the maker of the Steripath® Micro Initial Specimen Diversion Device, an FDA 510(k)-cleared solution designed to reduce blood culture contamination and improve diagnostic accuracy for sepsis testing. The Steripath Micro works by diverting the initial portion of a blood draw that can carry skin-derived contaminants, and has been clinically shown to reduce contamination rates by up to 88%. The company serves hospitals, healthcare systems, and clinical professionals with an evidence-backed platform supporting diagnostic stewardship, infection prevention, and improved patient outcomes.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Magnoliamedical.
Magnoliamedical didn’t post a salary, so this is our estimate from similar listings.
33% above the average for this role